Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Search
Filing date Form Description View
4

Statement of changes in beneficial ownership of securities

 View HTML
0001415889-22-002440.pdf
0001415889-22-002440.rtf
0001415889-22-002440.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001415889-22-002446.pdf
0001415889-22-002446.rtf
0001415889-22-002446.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001415889-22-002443.pdf
0001415889-22-002443.rtf
0001415889-22-002443.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001415889-22-002438.pdf
0001415889-22-002438.rtf
0001415889-22-002438.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001415889-22-002441.pdf
0001415889-22-002441.rtf
0001415889-22-002441.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001415889-22-002439.pdf
0001415889-22-002439.rtf
0001415889-22-002439.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001415889-22-002437.pdf
0001415889-22-002437.rtf
0001415889-22-002437.xls
8-K

Report of unscheduled material events or corporate event

 View HTML
0001104659-22-027659.pdf
0001104659-22-027659.rtf
0001104659-22-027659.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

 View HTML
0001558370-22-001316.pdf
0001558370-22-001316.rtf
0001558370-22-001316.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
S-8

Securities offered to employees pursuant to employee benefit plans

 View HTML
0001104659-22-024503.pdf
0001104659-22-024503.rtf
0001104659-22-024503.xls